Form 4: Medpace Holdings Director Exercises Stock Options
SEC Form 4 Filing
Cornelius P. McCarthy III, a director at Medpace Holdings, exercised stock options and acquired 62 shares of common stock on June 30, 2024.
Summary
- On June 30, 2024, Cornelius P. McCarthy III, a director of Medpace Holdings, Inc., executed a transaction involving restricted stock units.
- McCarthy exercised 62 restricted stock units, which converted into 62 shares of Medpace Holdings common stock.
- These restricted stock units were part of a grant of 249 units awarded on November 30, 2023, vesting in quarterly installments.
- Following the transaction, McCarthy directly owns 124 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report on insider trading activity, with no inherent positive or negative implications.
Industry Context
This is a routine disclosure of insider transactions, common for publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| November 30, 2023 | Reporting Person was granted 249 restricted stock units vesting in four approximately equal installments on March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024. |
| June 30, 2024 | Director exercised restricted stock units and acquired 62 shares of common stock. |
| July 02, 2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.